Amicus Therapeutics Inc Cash Flow-to-Debt Ratio
Amicus Therapeutics Inc cash flow-to-debt ratio. Amicus Therapeutics Inc (FOLD) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of $16.25 Million could theoretically repay 0% of its total liabilities ($675.63 Million) in one year. Check FOLD cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Amicus Therapeutics Inc (2005–2025)
Cash flow-to-debt ratio of Amicus Therapeutics Inc from 2005 to 2025. Historical debt coverage capacity for Amicus Therapeutics Inc across 21 annual periods. Check Amicus Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Amicus Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2005–2025)
Amicus Therapeutics Inc cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Amicus Therapeutics Inc. For the full cash flow conversion analysis, see Amicus Therapeutics Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | $33.15 Million | $675.63 Million | ▲ +185.5% |
| 2024 | -0.06x | $-33.89 Million | $590.99 Million | ▲ +48.7% |
| 2023 | -0.11x | $-69.09 Million | $617.71 Million | ▲ +59.6% |
| 2022 | -0.28x | $-166.57 Million | $601.12 Million | ▲ +18.2% |
| 2021 | -0.34x | $-202.49 Million | $597.77 Million | ▲ +12.9% |
| 2020 | -0.39x | $-233.29 Million | $600.14 Million | ▲ +42.0% |
| 2019 | -0.67x | $-250.42 Million | $373.78 Million | ▲ +0.2% |
| 2018 | -0.67x | $-299.95 Million | $447.04 Million | ▲ +14.6% |
| 2017 | -0.79x | $-215.49 Million | $274.17 Million | ▼ -253.3% |
| 2016 | -0.22x | $-150.53 Million | $676.69 Million | ▼ -24.5% |
| 2015 | -0.18x | $-100.14 Million | $560.55 Million | ▲ +69.6% |
| 2014 | -0.59x | $-51.67 Million | $87.79 Million | ▼ -5.1% |
| 2013 | -0.56x | $-45.79 Million | $81.81 Million | ▲ +32.2% |
| 2012 | -0.83x | $-33.74 Million | $40.87 Million | ▲ +32.8% |
| 2011 | -1.23x | $-49.42 Million | $40.20 Million | ▼ -318.6% |
| 2010 | -0.29x | $-13.98 Million | $47.62 Million | ▲ +90.8% |
| 2009 | -3.20x | $-43.37 Million | $13.54 Million | ▼ -401.8% |
| 2008 | -0.64x | $-36.86 Million | $57.73 Million | ▼ -368.2% |
| 2007 | 0.24x | $15.19 Million | $63.80 Million | ▲ +196.4% |
| 2006 | -0.25x | $-33.89 Million | $137.16 Million | ▲ +12.1% |
| 2005 | -0.28x | $-18.12 Million | $64.50 Million | — |